Phillip Wang

Papers

Total Citations

H-Index

About

Phillip Wang is a bioanalytical chemist whose work has advanced the field of dried blood spot (DBS) analysis, particularly for therapeutic drug monitoring. His most cited research focuses on developing semi-automated methods that streamline the quantitative determination of drugs in human blood, with his 2012 paper on guanfacine analysis (23 citations) serving as a key contribution. Wang pioneered a prototype robotic device that enables direct elution of DBS samples from paper cards onto online solid-phase extraction cartridges, coupled with high-performance LC-MS/MS analysis. This innovation significantly reduces manual handling, improves throughput, and enhances reproducibility in bioanalytical workflows. His work addresses critical challenges in DBS sampling—a minimally invasive technique especially valuable for pediatric and remote patient populations—by automating what was previously a labor-intensive process. Wang's contributions have practical implications for clinical pharmacokinetics and drug development, demonstrating how engineering solutions can bridge the gap between sample collection and robust quantitative analysis. His research continues to influence the design of automated bioanalytical platforms, making him a notable figure in the evolution of DBS technology for pharmaceutical applications.